|
||||||||
Legislative Update Week of March 15, 2004
Dr. Mark McClellan has been confirmed to head the Centers for Medicare and Medicaid Services. The Senate confirmation had been stalled until Dr. McClellan -- the Commissioner of the Food and Drug Administration (FDA) -- agreed to explain why the FDA opposes drug importation. In the past, one reason given was that of safety. In testimony last week before the Senate Finance Committee, McClellan said he would work with the Congress on bi-partisan legislation that would assure the safety of drugs imported from Canada. The issue of drug importation is picking up steam. Just last week, Senators Trent Lott (R-MS) and John Cornyn (R-TX) decided that when the issue comes up for a vote again, they will support it. Speaking to the issue of drug importation, Senator Lott said, “I cannot explain to my mother any longer why she should pay twice or two-thirds as much more than what they pay in Canada and Mexico. When the next vote comes, I’m switching my vote on the importation of drugs.” This week, TSCL will be presenting its annual “MVP” award for legislative action to Rep. Gil Gutknecht (R-MN) for his work on drug importation. His bill, HR 2427, passed the House on July 25, 2003. TSCL has long supported drug importation and continues to do so. We encourage our members and supporters to write or call their Senators urging them to support legislation to lower drug prices for all seniors. Sources: “Drug Importation Picks Up Support,” The Washington Post, March 12, 2004. “Dealing Drugs,” The Washington Post, March 15, 2004 March 2004 | ||||||||
|
|
||||||||
